Developer of proprietary biomedical technologies designed for the treatment of cancer through the measurement of drug resistance on patients. The company's technology uses a proprietary hydrogel that can grow tumors outside the human body and replicate drug resistance to eliminate the trial and error process involved in cancer treatment, thereby enabling patients to receive the right treatment sooner.